Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?

Identifieur interne : 007F47 ( Main/Merge ); précédent : 007F46; suivant : 007F48

DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?

Auteurs : Ann E. Kingsbury [Royaume-Uni] ; C. David Mardsen [Royaume-Uni] ; Oliver J. F. Foster [Royaume-Uni]

Source :

RBID : ISTEX:C8E569933545FDD274D81C83F49C4A25E8E90387

English descriptors

Abstract

DNA fragmentation was examined in situ in flashfrozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT‐mediated dUTP‐biotin 3′ end‐labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis‐like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.

Url:
DOI: 10.1002/mds.870130604

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:C8E569933545FDD274D81C83F49C4A25E8E90387

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, Ann E" sort="Kingsbury, Ann E" uniqKey="Kingsbury A" first="Ann E." last="Kingsbury">Ann E. Kingsbury</name>
</author>
<author>
<name sortKey="David Mardsen, C" sort="David Mardsen, C" uniqKey="David Mardsen C" first="C." last="David Mardsen">C. David Mardsen</name>
</author>
<author>
<name sortKey="Foster, Oliver J F" sort="Foster, Oliver J F" uniqKey="Foster O" first="Oliver J. F." last="Foster">Oliver J. F. Foster</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C8E569933545FDD274D81C83F49C4A25E8E90387</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130604</idno>
<idno type="url">https://api.istex.fr/document/C8E569933545FDD274D81C83F49C4A25E8E90387/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000862</idno>
<idno type="wicri:Area/Istex/Curation">000862</idno>
<idno type="wicri:Area/Istex/Checkpoint">003770</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kingsbury A:dna:fragmentation:in</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9827610</idno>
<idno type="wicri:Area/PubMed/Corpus">004316</idno>
<idno type="wicri:Area/PubMed/Curation">004316</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004465</idno>
<idno type="wicri:Area/Ncbi/Merge">005067</idno>
<idno type="wicri:Area/Ncbi/Curation">005067</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005067</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kingsbury A:dna:fragmentation:in</idno>
<idno type="wicri:Area/Main/Merge">007F47</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, Ann E" sort="Kingsbury, Ann E" uniqKey="Kingsbury A" first="Ann E." last="Kingsbury">Ann E. Kingsbury</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="David Mardsen, C" sort="David Mardsen, C" uniqKey="David Mardsen C" first="C." last="David Mardsen">C. David Mardsen</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Neurology, The National Hospital, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Foster, Oliver J F" sort="Foster, Oliver J F" uniqKey="Foster O" first="Oliver J. F." last="Foster">Oliver J. F. Foster</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>St. George's Hospital Medical School, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-11">1998-11</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="877">877</biblScope>
<biblScope unit="page" to="884">884</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C8E569933545FDD274D81C83F49C4A25E8E90387</idno>
<idno type="DOI">10.1002/mds.870130604</idno>
<idno type="ArticleID">MDS870130604</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Apoptosis</term>
<term>Cadaver</term>
<term>DNA Fragmentation</term>
<term>DNA fragmentation</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>In Situ Nick-End Labeling</term>
<term>Male</term>
<term>Movement Disorders (pathology)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson's disease</term>
<term>Perimortem factors</term>
<term>Postmortem brain</term>
<term>Substantia Nigra (pathology)</term>
<term>TUNEL</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Movement Disorders</term>
<term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Apoptosis</term>
<term>Cadaver</term>
<term>DNA Fragmentation</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>In Situ Nick-End Labeling</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">DNA fragmentation was examined in situ in flashfrozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT‐mediated dUTP‐biotin 3′ end‐labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis‐like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.</div>
</front>
</TEI>
<double doi="10.1002/mds.870130604">
<ISTEX>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, Ann E" sort="Kingsbury, Ann E" uniqKey="Kingsbury A" first="Ann E." last="Kingsbury">Ann E. Kingsbury</name>
</author>
<author>
<name sortKey="David Mardsen, C" sort="David Mardsen, C" uniqKey="David Mardsen C" first="C." last="David Mardsen">C. David Mardsen</name>
</author>
<author>
<name sortKey="Foster, Oliver J F" sort="Foster, Oliver J F" uniqKey="Foster O" first="Oliver J. F." last="Foster">Oliver J. F. Foster</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C8E569933545FDD274D81C83F49C4A25E8E90387</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130604</idno>
<idno type="url">https://api.istex.fr/document/C8E569933545FDD274D81C83F49C4A25E8E90387/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000862</idno>
<idno type="wicri:Area/Istex/Curation">000862</idno>
<idno type="wicri:Area/Istex/Checkpoint">003770</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kingsbury A:dna:fragmentation:in</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, Ann E" sort="Kingsbury, Ann E" uniqKey="Kingsbury A" first="Ann E." last="Kingsbury">Ann E. Kingsbury</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="David Mardsen, C" sort="David Mardsen, C" uniqKey="David Mardsen C" first="C." last="David Mardsen">C. David Mardsen</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Institute of Neurology, The National Hospital, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Foster, Oliver J F" sort="Foster, Oliver J F" uniqKey="Foster O" first="Oliver J. F." last="Foster">Oliver J. F. Foster</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>St. George's Hospital Medical School, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-11">1998-11</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="877">877</biblScope>
<biblScope unit="page" to="884">884</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C8E569933545FDD274D81C83F49C4A25E8E90387</idno>
<idno type="DOI">10.1002/mds.870130604</idno>
<idno type="ArticleID">MDS870130604</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Apoptosis</term>
<term>DNA fragmentation</term>
<term>Parkinson's disease</term>
<term>Perimortem factors</term>
<term>Postmortem brain</term>
<term>TUNEL</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">DNA fragmentation was examined in situ in flashfrozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT‐mediated dUTP‐biotin 3′ end‐labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis‐like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.</div>
</front>
</TEI>
</ISTEX>
<PubMed>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, A E" sort="Kingsbury, A E" uniqKey="Kingsbury A" first="A E" last="Kingsbury">A E Kingsbury</name>
<affiliation wicri:level="3">
<nlm:affiliation>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mardsen, C D" sort="Mardsen, C D" uniqKey="Mardsen C" first="C D" last="Mardsen">C D Mardsen</name>
</author>
<author>
<name sortKey="Foster, O J" sort="Foster, O J" uniqKey="Foster O" first="O J" last="Foster">O J Foster</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1998">1998</date>
<idno type="RBID">pubmed:9827610</idno>
<idno type="pmid">9827610</idno>
<idno type="doi">10.1002/mds.870130604</idno>
<idno type="wicri:Area/PubMed/Corpus">004316</idno>
<idno type="wicri:Area/PubMed/Curation">004316</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004465</idno>
<idno type="wicri:Area/Ncbi/Merge">005067</idno>
<idno type="wicri:Area/Ncbi/Curation">005067</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005067</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kingsbury A:dna:fragmentation:in</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?</title>
<author>
<name sortKey="Kingsbury, A E" sort="Kingsbury, A E" uniqKey="Kingsbury A" first="A E" last="Kingsbury">A E Kingsbury</name>
<affiliation wicri:level="3">
<nlm:affiliation>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Parkinson's Disease Society Brain Research Centre, Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mardsen, C D" sort="Mardsen, C D" uniqKey="Mardsen C" first="C D" last="Mardsen">C D Mardsen</name>
</author>
<author>
<name sortKey="Foster, O J" sort="Foster, O J" uniqKey="Foster O" first="O J" last="Foster">O J Foster</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1998" type="published">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Apoptosis</term>
<term>Cadaver</term>
<term>DNA Fragmentation</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>In Situ Nick-End Labeling</term>
<term>Male</term>
<term>Movement Disorders (pathology)</term>
<term>Parkinson Disease (pathology)</term>
<term>Substantia Nigra (pathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Movement Disorders</term>
<term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Apoptosis</term>
<term>Cadaver</term>
<term>DNA Fragmentation</term>
<term>Female</term>
<term>Humans</term>
<term>Hydrogen-Ion Concentration</term>
<term>In Situ Nick-End Labeling</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">DNA fragmentation was examined in situ in flash-frozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT-mediated dUTP-biotin 3' end-labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis-like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007F47 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 007F47 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:C8E569933545FDD274D81C83F49C4A25E8E90387
   |texte=   DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024